Business programme

01 December 10:00–11:15
 RIA Novosti, Moscow, Zubovsky Boulevard, 4, Bolshoy hall
Values-Based Healthcare: Through the Lens of Economic Challenges
Strategic session Today’s healthcare system is heading down a path of exponential development of high-cost innovative technologies. At the beginning of 2021, the national healthcare system received a reduction in funding from the federal budget, with further cuts expected in the coming years. In light of these conditions, what is required is an approach that focuses on the unconditional quality of medical care with maximum benefit to patients. Strategies should be based on the principles of personalized medicine and comprehensive solutions at every stage of medical care, from prevention and treatment to patient rehabilitation. Values-based healthcare outlines efforts to stop the progression of disease, prevent occurrence of disease, support early detection and continually monitor patients’ health status based on IT and telemedicine technologies. It highlights the principle of participation by taking into account a ‘second opinion’, as well as the introduction of tools to analyse needs and patient satisfaction. The values-based healthcare model is best equipped to support the achievement of national projects, increase life expectancy and promote the health of the working-age population, while contributing to the optimization of funding, a key criterion for which is the quality of services provided and the effectiveness of treatments using innovative technologies and drugs.
• What challenges is the healthcare system facing as a result of the pandemic and how well-equipped is the national healthcare system to respond to the requirements of a values-based approach?
• Which areas of the medical care system need to be modernized as a priority in the context of values-based healthcare?
• Which solutions for modernizing the healthcare system can help in the achievement of the goals of reducing mortality from circulatory disease and improving the quality and availability of medical care?
• What tools for improving the drug supply system can help to prevent the development of socially significant diseases?
• What can be done to develop patient-focused healthcare and turn patients into reliable partners of the state willing to fight for their own wellbeing?
Moderator:
Evelina Zakamskaya — Anchor, Russia 24; Editor-in-Chief, Doctor Channel
Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. Since 2017 - Editor-in-Chief, Doctor Channel. She is married with two daughters.
Panellists:
Svetlana Axelrod — Director, WHO Global Noncommunicable Diseases Platform (online)
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Galina Izotova — Deputy Chairman, Accounts Chamber of the Russian Federation
Born on May 3, 1960 in Cherepovets, Vologda Region.

1983 - Graduated from Leningrad Voznesensky Institute of Finance and Economics. 1983 - graduated from the N.A. Voznesensky Leningrad Institute of Finance and Economics with a degree in finance and credit. 2001 - Moscow State Institute of International Relations (University) of the Ministry of Foreign Affairs of Russia, specializing in state and municipal management.
2006-2007 - Deputy Plenipotentiary Representative of the President of the Russian Federation in the North West Federal District.
2007-2011 - Deputy of the State Duma of the fifth convocation, First Deputy Chairman of the State Duma Committee for Federation Affairs and Regional Policy.
2012-2014 - Deputy Plenipotentiary Representative of the President of the Russian Federation in the Volga Federal District.
2014-2015 - Chairman of the Management Board of the joint-stock company Federal Corporation for Development of Small and Medium-Sized Entrepreneurship.
2016-2017 - Chairman of the Board of Directors of CJSC Drobmash.
2017-2019 - Member of the General Council of Delovaya Rossiya LLC, Chairman of the Financial Services Committee.
2019 - Advisor to the General Director for corporate programs of FSUE Russian Post.
September 25, 2019 - appointed by the Federation Council to the position of Deputy Chairman of the Accounts Chamber of the Russian Federation on the recommendation of the President of Russia.
D. in Economics, "Honored Economist of the Russian Federation", has the title of "Excellent Financial Worker".
Dmitry Morozov — Director, Veltischev Research and Clinical Institute for Pediatrics of the Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation
Ruslan Khalfin — Director, Higher School of Healthcare Management, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation
Ruslan Khalfin is Director of the Higher School of Healthcare Management at the I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, a medical doctor, Professor, winner of a State Prize of the Russian Federation in the field of science and technology, Honoured Doctor of the Russian Federation, and Actual State Councillor of Russian Federation, 2nd class. He worked for more than 30 years in healthcare in the Sverdlovsk Region. He has also worked in the central office of the Ministry of Health of the Russian Federation and the Ministry of Health and Social Development of the Russian Federation, and has held the post of Deputy Minister under three federal ministers. He has been actively involved in reforming the sector, and was one of the originators and implementers of the national ‘Health’ project. For the past 11 years he has been President of the medical insurance company MAKS-M, part of the MAKS Insurance Group. Chair of the Board of the Russia-wide public organization ‘The Russian Association for the Organization of Health and Public Health’.
Dmitry Khubezov — Deputy of the State Duma of the Federal Assembly of the Russian Federation; Chairman of the State Duma Committee of the Russian Federation on Health Protection
Front row participants:
Alisa Dzhangiryants — Director of Market Access and Pricing, Bristol-Myers Squibb
Aleksandr Petrov — Head of the Subcommittee on Circulation of Medicines, Development of the Pharmaceutical and Medical Industry, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection (online)
Ekaterina Pogodina — Director General, Managing Director of Janssen Pharmaceutical Companies, Johnson & Johnson Russia & CIS
Katerina began her career with Janssen in 2001, holding a number of positions in the Sales, Marketing and Market Access teams. She has been a member of the Russian board of directors since 2010 and was appointed Country Manager Russia in 2015, and then she was promoted to the position of Managing Director Russia & CIS in 2017. In April 2019 Katerina was appointed CEO of Johnson & Johnson Russia & CIS.
Throughout her 17-year career with Janssen, Katerina has consistently demonstrated high standards of quality and strong results. She led the launch of a whole range of new products and work across a number of therapeutic areas, as well as establishing several new business units. In her role as Commercial Operations Director, Russia, Katerina successfully led commercial teams in close collaboration with other departments, which yielded great business results and drove the company’s overall success.
Katerina graduated with distinction from the International University in Moscow, where she studied law. She also completed specialist education for senior executives at the London School of Economics and Political Science and Moscow School of Management Skolkovo.
Since 2015 Katerina has been a member of the board of directors of the Association of International Pharmaceutical Manufacturers (AIPM). Forbes magazine contributor, speaker of the Second Eurasian Women’s Forum.
01 December 12:00–13:15
 RIA Novosti, Moscow, Zubovsky Boulevard, 4, Presidential hall
The Fight Against Cancer: Challenges, Solutions, Outcomes
Panel session In 2020, mortality from neoplasms in Russia amounted to 289,900 patients, which is 1.9% lower than the previous year. The strategy for fighting cancer formed the basis of the federal project of the same name, which is being implemented as part of the national Healthcare project and outlines the modernization of cancer care centres, the creation of outpatient cancer centres, and the training of highly qualified oncologists. Provisions should be made for improved availability and quality of cancer care at all stages in the context of a patient-focused approach. The most important element of the project is a set of solutions aimed at preventing the incidence of cancer, including through the availability of timely medical examinations and screenings, increased cancer awareness among doctors and patients, and the prevention of risk factors. According to the WHO, approximately one third of all cancer-related deaths are caused by unhealthy lifestyles, putting the promotion of healthy lifestyles at the forefront of government strategies to combat the spread of cancer.
• To what extend does the rollout of the ‘Fight Against Cancer’ project meet the goals set out in the context of the pandemic, and what opportunities are open to Russian citizens today in the fight against cancer?
• Which challenges necessitate the search for new approaches to providing medical care for cancer patients?
• How can the status of cancer care in the Russian regions be evaluated?
• How can the availability and quality of cancer care provided within the compulsory health insurance system be improved? Can the new procedure for providing cancer care be understood as a patient-focused solution?
• What tools and solutions can drive progress in the implementation of the national cancer programme and change the face of the system for delivering care to cancer patients in the near future?
• What measures can help to raise awareness of the cancer threat among the Russian population and improve cancer awareness among patients and doctors alike?
• How can all the necessary information about cancer prevention be provided to citizens? How can the public be incentivized to adopt healthy lifestyles?
Moderator:
Vitaliy Omelyanovskiy — General Director, Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation
Born July 27, 1964 in Obninsk, Kaluga Oblast.
In 1987, he graduated from the Pirogov Russian National Research Medical University with a degree in General Medicine. After graduation he stayed in the university, where he rose from postgraduate to professor of the department of clinical pharmacology.
In 1998 he graduated from the Russian Presidential Academy of National Economy and Public Administration of the Russian Federation with a degree in state and municipal management, with the qualification of economist-financier.
In 2002, he defended the first doctoral dissertation in the Russian Federation on clinical and economic analysis and pharmacoeconomics.
From 2009 to 2012 he was. - Vladimir Potanin was Director of the Research Institute for Clinical and Economic Expertise and Pharmacoeconomics at the N.I. Pirogov Russian National Research Medical University, Federal State Autonomous Educational Institution of Higher Professional Education, Ministry of Health Care of the Russian Federation.
From 2012 to 2020, she was Head of the Research Laboratory of the N.I. Pirogov Russian National Research Medical University. - Head of the Research Laboratory for Technology Assessment in Healthcare at the Institute of Applied Economic Research of the Russian Presidential Academy of National Economy and Public Administration, a federal state budget-funded educational institution of higher education.
Since 2014. - Head of the Healthcare Finance Center of the Federal State Budgetary Institution "Research Financial Institute" of the Ministry of Finance of the Russian Federation. Ministry of Finance of the Russian Federation.
Since 2015. - General Director of the Federal State Budgetary Institution "Center for Expertise and Quality Control of Medical Care" of the Ministry of Health of the Russian Federation.
Since 2020. - Head of the Department of Economics, Management and Assessment of Healthcare Technologies of the Federal State Budgetary Educational Institution of Additional Professional Education "Russian Medical Academy of Continuing Professional Education" of the Ministry of Healthcare of the Russian Federation.

Member of the Dissertation Council D 208.088.01.
Head of the Expert Council on Health Care of the Federation Council Committee on Social Policy, Expert of the Analytical Centre for the Government of the Russian Federation.
Chief Clinical Pharmacologist, Ministry of Health, Moscow Region.
Chief editor of scientific journals, Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology" and "Medical Technology. Evaluation and Choice".
She is an author of three patents of the Russian Federation, two monographs, educational and methodical manuals for physicians, and more than 140 scientific papers published in Russian and foreign medical journals.
Doctor of Medicine (2002), Professor (2007). Under his supervision V.V. Omelyanovsky defended one doctoral thesis and seven Ph. Currently supervises the theses of two doctoral students and two doctoral candidates.
He is the President of the Russian branch of the International Society for Pharmacoeconomic Research and Outcome Evaluation (ISPOR).
He is a laureate of the Russian Federation Government Award in Science and Technology, has certificates of merit from the President of the Russian Federation and the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, and has received commendations from the Chairman of the Federation Council of the Federal Assembly of the Russian Federation, the Analytical Center of the Russian Federation Government, the Russian Academy of National Economy and Public Administration under the President of the Russian Federation, and the Sverdlovsk Oblast Government.
Panellists:
Andrey Kaprin — General Director, Federal State Budgetary Institution National Medical Research Radiological Centre of the Ministry of Health of the Russian Federation; Chief Oncologist of the Russian Federation
· Doctor of Medical Sciences, Professor, Academician of RAS, Honored Doctor of the Russian Federation.
· Director General of the National Medical Research Radiological Centre (NMRRC) of Ministry of Health of the Russian Federation, Director of the P.A. Herzen Moscow Cancer Research Institute, a branch of NMRRC.
· He is one of the leading specialists in the Russian Federation in the field of diagnosis and treatment of oncological diseases. Throughout the scientific and therapeutic activity, Andrey Kaprin conducts a purposeful development of modern methods of surgical and combined treatment of kidney, bladder, prostate and other localizations.
· Since 2014, Andrey Kaprin is heaing the first Russian scientific medical cluster in the field of oncology - the Federal State Budgetary Institution "National Medical Research Radiological Centre" of Ministry of Health of the Russian Federation, which was established on the basis of three leading medical centers - P. Herzen, A.Tsyb MRRC, and N. Lopatkin Research Institute of Urology and Interventional Radiology.
· At present, being the head of the NMRRC of Ministry of Health of the Russian Federation, being an academician of the Russian Academy of Sciences in oncoradiology, he supervises the development of nuclear medicine, radiology and radiotherapy in our country. He has taken charge of most complex and promising areas in the industry: the technical re-equipment of the radiation therapy departments of the regions, the creation of a program and a center for the development of contact methods of irradiation, the introduction and expansion of the first national medical proton center in the country, the introduction of modern methods of training specialists in radiology and radiotherapy, iIncluding telecommunication training and master classes in the regions, many of which are conducted by himself.
· Every year Andrey Kaprin performs over 300 complex surgical interventions for various oncological diseases.
· He has trained more than 300 doctors, including residents and graduate students. Under his leadership, 27 dissertations for the degree of candidate of medical sciences and 9 doctoral dissertations were prepared and successfully defended. The result of many years of hard work was the publication of more than 700 printed scientific works.
Konstantin Laktionov — Deputy Director for Clinical Work, Trapeznikov Research Institute of Clinical Oncology; Director, Department of Chemotherapy No. 17, Blokhin National Medical Research Center of Oncology of the Russian Ministry of Health
Svetlana Strigunkova — Deputy Chairman of the Government of Moscow Region; Minister of Health of Moscow Region
Dmitry Khubezov — Deputy of the State Duma of the Federal Assembly of the Russian Federation; Chairman of the State Duma Committee of the Russian Federation on Health Protection
Olga Tsareva — Deputy Chair, Federal Fund for Mandatory Medical Insurance
Front row participants:
Svetlana Bokova — Chair of the Executive Committee, Movement Against Cancer
Irina Borovova — President, Association of Cancer Patients "Zdravstvuy!"
01 December 12:00–13:15
 RIA Novosti, Moscow, Zubovsky Boulevard, 4, Bolshoy hall
Post-COVID-19 Recovery at the Heart of Government Strategy
Panel session It has become clear that the issues associated with the long-term consequences of the COVID-19 pandemic are not only having a significant impact on public health but are adversely affecting the economy and are placing a strain on the healthcare system. In June 2021, President of the Russian Federation Vladimir Putin announced the creation of a programme for the development of a post-COVID medical rehabilitation system for the period until 2026. It is necessary to ensure the resolution of approaches for the medical treatment of post-COVID syndrome (long COVID) and the development of specialist infrastructure, including efforts to provide medical organizations with equipment, train additional personnel and create the necessary conditions for the implementation and large-scale rollout of leading aftercare practices and developments. Members of the medical community must be able to share information and access the latest post-COVID recovery developments and technologies. As things stand, there has been no consistent approach to the fight against long COVID, and there are no targeted drug treatments. What is needed is a state programme to support scientific and medical research into long COVID so that future research can identify the causes behind COVID symptoms and find ways to prevent the development of severe complications. A comprehensive range of measures to support patients to overcome the effects of coronavirus infection should help them to recover quickly and make a full return to a normal life.
• What steps must be taken in order to implement the medical recovery programme for people infected with coronavirus?
• What resources need to be drawn on in order to provide care for all patients suffering from long COVID?
• What state support is needed for the development of scientific and medical research into long COVID and the formulation of approaches to aftercare?
• What contemporary developments in science and medicine, including in clinical pharmacology, can bring us closer to solving the problem of long COVID?
• What medical methods and technologies, including new innovations, are already being successfully applied to treat patients recovering from coronavirus? Which tools can be used to roll out best practice?
Moderator:
Alexey Bezymyanny — Head of the Directorate for the Coordination of Medical Organizations of the Moscow Healthcare Department; PhD
Panellists:
Galina Karelova — Deputy Chairman of the Federation Council of the Federal Assembly of the Russian Federation (online)
Deputy Chairperson of the Federation Council of the Russian Federation
Born on 29 June 1950 in the city of Nizhnyaya Salda, Sverdlovsk Region. In 1972, she graduated from the Sergei Kirov Urals Polytechnic Institute with a degree in engineering and economics. PhD in Economics and DSc in Social Sciences, professor. For 20 years she was engaged in teaching and research. Author of over 150 papers on economic, social and political issues.
Since 1990 – delegate, Deputy Speaker (1992–1993) of the Sverdlovsk Regional Parliamentarian Council.
1994–1996 – Deputy of the Council of Federation of the Federal Assembly of the Russian Federation, Chairperson of the Federation Council Committee on Social Policy.
1996–1997 – Deputy of the State Duma of the Federal Assembly of the Russian Federation, Chairman of the Subcommittee on International Humanitarian, Scientific and Cultural Cooperation of the State Duma Committee on International Affairs.
Since 1997 – Deputy and since 2000 – First Deputy Minister of Labour and Social Affairs of the Russian Federation.
April 2003 – March 2004 – Deputy Prime Minister of the Russian Federation on Social Affairs.
April 2004 – December 2007 – Chairperson of the Social Insurance Fund of the Russian Federation.
On 2 December 2007, she was elected a deputy to the Fifth State Duma, Deputy Speaker of the State Duma Committee on Budget and Taxes.
On 4 December 2011, she was elected a deputy to the Sixth State Duma, First Deputy Chair of the State Duma Committee on Labour, Social Policy and Veteran Affairs.
Since 22 September 2014, she is a Representative of the executive authority of the Voronezh Region in the Federation Council. Deputy Speaker of the Federation Council of the Federal Assembly of the Russian Federation, member of the Federation Council Committee on Social Policy. Initiator and drafter of more than 40 laws, including laws on social protection. Full State Counsellor 1st Class of the Russian Federation. Decorated with state orders and medals.
Наталья Мокрышева — Director, National Medical Research Center for Endocrinology Ministry of Health of the Russian Federation
Aleksandr Petrov — Head of the Subcommittee on Circulation of Medicines, Development of the Pharmaceutical and Medical Industry, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection (online)
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Front row participants:
Anna Bogolepova — Professor, Department of Neurology, Neurosurgery and Medical Genetics, Pirogov Russian National Research Medical University of the Russian Ministry of Health
Galina Ignatova — Head of Therapy, Institute of Continuing Professional Education of the South Ural State Medical University of the Ministry of Health of the Russian Federation; chief external pulmonary expert of the Ministry of Health of the Russian Federation for the Ural Federal District; Doctor of Medicine; professor
Aleksandr Lila — Director, V.A. Nasonova Research Institute of Rheumatology
Anatoly Fesyun — Acting Director, Federal State Budgetary Institution "National Medical Research Center for Rehabilitation and Balneology" of the Ministry of Health of Russia
01 December 13:45–15:00
 RIA Novosti, Moscow, Zubovsky Boulevard, 4, Presidential hall
Stopping HIV: Steps Towards Implementing the Government Strategy
Panel session This session is timed to coincide with World AIDS Day In 2020, the rate of HIV infection decreased by 25% compared with the previous reporting period, but the epidemiological situation with regard to HIV in Russia remains a cause for concern. At the end of last year, the government established a state strategy to counter the spread of HIV in Russia for the period to 2030. This became a new springboard for policy measures to prevent the spread of the life-threatening infection nationwide. According to the state strategy, the entire Russian population should be given access to proper screening for HIV, the use of antiretroviral therapy should be scaled up significantly and the risk of transmission of HIV from mother to child should be reduced. Among other goals, public awareness of the virus should be higher. There is significant progress being made in the treatment of HIV today, and patients are able to lead productive and full lives. According to the Russian Ministry of Health, HIV infections in Russia began to plateau at the end of last year. A further decrease in the incidence and spread of HIV in Russia will be possible if a vaccine is developed. In this respect, looking to the experience of developing drugs and vaccines to fight the SARS-CoV-2 coronavirus offers a progressive solution.
• What changes have been made to strategies to prevent the spread of HIV infection in Russia as a result of the pandemic?
• How can the incidence of HIV infection be reduced and how can the rate of detection of HIV infections be improved?
• What is the role of the regions in terms of putting forward measures for the implementation of the state strategy?
• What regulatory decisions should be made in order to simplify and expand access to antiretroviral therapy and innovative medical technologies for HIV patients?
• What public policy measures can help to drive the development and production of innovative drugs in Russia?
• Which scientific discoveries could bring forward the development of an HIV vaccine?
• What measures could be taken to increase public awareness of HIV and prevent discrimination against people living with HIV?
Moderator:
Evelina Zakamskaya — Anchor, Russia 24; Editor-in-Chief, Doctor Channel
Evelina Zakamskaya was born on November 17, 1977, in Baku, and graduated from the Faculty of Philology at Tver State University. She is a presenter for Radio Mayak and for Mir, a television and radio company. Since 2006, she has been an anchor for television channel Russia 24. She writes and presents Mnenie (Opinion), a talk show covering social and political issues, and Idei, menyayushchie mir (World-Changing Ideas), a series of popular science programmes. Evelina Zakamskaya moderates Russia 24 sessions at major international forums. Since 2017 - Editor-in-Chief, Doctor Channel. She is married with two daughters.
Panellists:
Melita Vujnovic — Representative to the Russian Federation, Head of Office, World Health Organization Office in the Russian Federation
Oleg Gridnev — Deputy Minister of Health of the Russian Federation
Alexey Mazus — Chief External Expert in HIV of the Ministry of Health of the Russian Federation and Moscow Healthcare Department
Benjamin Young — Chief Medical Officer, ViiV Healthcare (online)
Front row participants:
Vladimir Gushchin — Head, Laboratory of Mechanisms for the Population Variability of Pathogenic Microorganisms, Ivanovsky Institute of Virology, Gamaleya National Centre of Epidemiology and Microbiology
Larisa Karaulova — Head, Department for Preventing and Combatting AIDS and Infectious Diseases, Clinical Hospital No. 172, Branch No. 2, Federal Scientific and Clinical Centre for Medical Radiology and Oncology of the Federal Medical-Biological Agency; Chief External Expert on HIV Infection, Federal Medical-Biological Agency
Igor Pchelin — Chairman, Shagi Regional Charitable Public Foundation for the Fight against AIDS
Kamil Saytkulov — Head of Communications and Government Affairs, GSK Russia
Denis Shtanev — Chief Medical Officer, Stavropol Regional Centre for the Prevention and Control of AIDS and Infectious Diseases; chief external expert on HIV diagnostics and treatment of North Caucasian Federal District
01 December 13:45–15:00
 RIA Novosti, Moscow, Zubovsky Boulevard, 4, Bolshoy hall
The Fight Against Diabetes: State Strategy and Practice
Panel session After the federal target programme on Diabetes was shut down in 2012 the number of patients with diabetes in Russia began to rise rapidly, with the country now seeing some of the highest rates globally. The number of patients with diabetes has more than doubled in the intervening period. Furthermore, the asymptomatic course of diabetes means that the actual prevalence exceeds official statistics by at least twofold, meaning that around 10 million people in Russia are living with the condition. The fight against diabetes should be comprehensive and involve all aspects of public health, including efforts to ensure the monitoring and availability of systematic medical provision from outpatient to inpatient care, the strengthening of human resources, support for innovative smart drug technologies at all stages from development to integration into the public health system, and the systematic elimination of risk factors including the identification of at-risk groups, lifestyle changes and the promotion of a culture of responsible public attitudes towards health.
• What measures are being taken to reduce the diabetes burden in Russia and how are they contributing to the achievement of the national goals? What challenges is the system of medical care and drug supply for patients with diabetes currently facing and how can it be improved?
• What state support measures can improve patient access to innovative diabetes therapies? Will the federal programme to fight diabetes be able to solve this problem and how?
• What criteria and principles should be used to guide decisions on public funding for new diabetes treatment technologies?
• What difficulties are patients facing in terms of accessing medical care today?
• What new technologies are of greatest benefit to patients?
• What is the readiness of Russia’s federal subjects in terms of adopting a comprehensive solution to the problems associated with diabetes?
Moderator:
Anton Danilov-Danilyan — Chairman of the Expert Council, Industrial Development Fund
Cochairman, Delovaya Rossiya (non-profit organization)
Chairman, Oboronitelnye Sistemy, JSC
Born in Moscow in 1966.
Anton Danilov-Danilyan graduated from the School of Economics of Moscow State University and got a PhD on inflation processes in economy.
2004-2005 – Board Member and Senior Analyst, Oboronprom
September 2012 – Cochairman, Delovaya Rossiya
January 2016 – Chairman of Oboronitelnye Sistemy
Previously Mr. Danilov-Danilyan was part of expert group on economics for the President of the Russian Federation and the National Bank Council, as well as the Head of the Economics Department for the the President of the Russian Federation and Board Member for many large companies partially owned by the state.
Public activity:
- Chairman of the Public Council, the Ministry of Trade and Industry of the Russian Federation.
- Member of the Expert Council, the Government of the Russian Federation.
- Chairman of the Expert Council, Russian Foundation for Technological Development.
- Chairman of the Investment Council, the Chamber of Commerce and Industry of the Russian Federation.
- Member of the Expert Council, Strategic Investment Agency.
Awards:
- Medal, 2nd degree Order “For Merit to the Fatherland”.
- Medal for Merit in Population Census.
- 5 Notes of Acknowledgement from the President of the Russian Federation.
- Certificate of Merit from the Government of the Russian Federation.
- Note of Acknowledgement from the Chairman of the Russian Federation.
Panellists:
Vasily Ignatiev — General Director, R-Pharm
Born in Moscow, Russia on 27 November 1968.
Ignatiev holds an MD – diploma with honours from the I.M. Sechenov First Moscow State Medical University. Expert in clinical pharmacology. Holds a Candidate of Medical Research Degree. Studied at Columbia University College of Physicians and Surgeons (New York, USA). Holds MBA degrees from Moscow International Higher Business School MIRBIS and London Guildhall University (now part of the London Metropolitan University).
For 7 years Ignatiev worked in the Russian branch of the international pharmaceutical company Bristol-Myers Squibb in the positions of Product Manager, Franchise Manager, Marketing Director.
For 5 years Ignatiev served in the Russian branch of the international pharmaceutical company AstraZeneca in the leading positions of Marketing Director and Sales Director.
In 2008, Ignatiev was appointed Director for Business Development in CJSC R-Pharm, a Russian pharmaceutical company. And now he is the Chief Executive Officer.
In 2018 Ignatiev was elected to become Vice Chair of the Board of the Association of International Pharmaceutical Manufacturers.
Oliver Koehncke — General Director, Boehringer Ingelheim Russia
Наталья Мокрышева — Director, National Medical Research Center for Endocrinology Ministry of Health of the Russian Federation
Aleksandr Petrov — Head of the Subcommittee on Circulation of Medicines, Development of the Pharmaceutical and Medical Industry, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection (online)
Vladimir Chulanov — Deputy Director for Research and Innovation Development, National Medical Research Center for Phtisiopulmonology and Infectious Diseases; Chief External Expert in Infectious Diseases of the Ministry of Health of the Russian Federation (online)
Front row participants:
Andrey Sarana — First Deputy Chairman of the Health Committee of St. Petersburg (online)
Ramil Khabriev — Academic Supervisor, N.A. Semashko National Research Institute of Public Health
Ramil Khabriev is an academician at the Russian Academy of Sciences.
Ramil Khabriev is an Honoured medical Doctor of the Russian Federation. He received the Russian government Science and Technology Prize in 2008 and was honoured with an Order of Merit to the Fatherland, IV class, as well as other Russian government awards.
He graduated from the S.V. Kurashov Kazan Medical Institute.
He served as Minister of Healthcare of the Republic of Tatarstan from 1989 to 1994 and as a people’s deputy and member of the Council of Nationalities for the Supreme Council of the Russian Federation, from 1990 to 1993.
From 1994 to 2001, he was head of the Department of State Control of Quality, Effectiveness, and Medication Safety at the Russian Ministry of Healthcare.
He served as General Director of Biopreparat, in Moscow, from 2001 to 2004.
From 2004 to 2009, Ramil Khabriev was head of the Federal Service for the Monitoring of Healthcare (Roszdravnadzor).
He was the deputy director of the Department of Social Development of the Government of the Russian Federation, from 2007 to 2009.
From 2009 to 2012, he was the First Vice Rector of the N.I. Pirogov Russian National Research Medical University.
Marina Shestakova — Deputy Director of the Center- of the Diabetes Institute, Endocrinology Research Centre of the Ministry of Health of the Russian Federation (online)
01 December 15:30–16:45
 RIA Novosti, Moscow, Zubovsky Boulevard, 4, Bolshoy hall
Pursuing the 2024 Targets: Prevention and Treatment of Cardiovascular Disease
Panel session Diseases of the circulatory system account for 47% of mortality in Russia. The programme of preferential medical provision for patients with acute cardiovascular conditions was expanded in 2021 as an additional measure in the prevention of premature mortality related to cardiovascular disease. The majority of fatalities, however, are the result of chronic illnesses of the circulatory system. Efforts to counter this should be based on an integrated cardiovascular risk management system, as is the case with acute illnesses. Taking into account the potential of modern drug therapies, the prioritization of early outpatient diagnostics and measures to prevent complications, this approach should reduce mortality rates from circulatory disease, including among the working age population.
• How has the experience of the COVID-19 pandemic affected improvements to the cardiac care system in Russia?
• How will the programme to expand preferential medical provision for patients with cardiovascular disease affect efforts to achieve the federal project targets?
• Will increasing the availability of outpatient drug therapies in cases of chronic cardiovascular disease reduce the economic burden?
• What measures to systematically improve the provision of medical care for patients with acute and chronic cardiovascular disease can help to reduce mortality from circulatory disease?
• What role does a personalized approach to early diagnosis play in the system for managing cardiovascular risk?
• What are the prospects for public policy aimed at promoting healthy lifestyles as a core preventive measure against cardiovascular disease?
Moderator:
Simon Matskeplishvili — Deputy Scientific Director, Lomonosov Moscow State University Clinic; Member of the Board, Russian Society of Cardiology
Simon Matskeplishvili, MD, PhD, FESC, FACC, is a Professor of Cardiology and a Chief Scientific and Clinical Researcher at the Bakoulev Scientific Center for Cardiovascular Surgery in Moscow and an adjunct professor of life sciences at the Moscow Institute of Physics and Technology.
He also serves as a member of the Education, Certification and Accreditation, European Communities Committees of the European Association of Cardiovascular Imaging.
He graduated with honors from the Moscow Medical Academy in 1994 and had his postgraduate training and fellowship in cardiology at the Clinico-Diagnostic Department of the Bakoulev Center.
In 1997-1998 he received a degree of the International Master in Cardiology from the Institute of Clinical Physiology of the National Research Council of Italy in Pisa.
Simon Matskeplishvili is a Fellow of the European Society of Cardiology and a Fellow of the American College of Cardiology. He has received numerous honours and awards, both in Russia and internationally, including the European Cardiology award in 2001. He is a founder and a Chairman of the echocardiography section of the Russian society of cardiology. In 2007 he became a full professor of cardiology.
For the development of new non-invasive method of intracardiac blood flow evaluation in 2012 he was awarded a State Prize of the Government of Russian Federation in science and technology.
In 2013 he was a captain of the Russian team to win an ESC Cardiology Quiz “Primus inter pares” at the European Congress of Cardiology in Amsterdam.
In 2012 Professor Simon Matskeplishvili had organized and implemented the Educational Program for cardiologists and internal medicine physicians in Moscow. He also conducts an English-language elective course “Amazing Cardiology” in cardiology, cardiac surgery and cardiovascular imaging at the Faculty of Medicine of the Lomonosov Moscow State University.
The Board of the European Society of Cardiology has appointed Simon Matskeplishvili as the Coordinator of the Congress Programme Committee of the European Society of Cardiology Congress 2015-2016.
Panellists:
Elena Golukhova — Director, Bakulev Scientific Centre for Cardiovascular Surgery of the Ministry of Health of the Russian Federation; Doctor of Medicine; professor; member of the Russian Academy of Sciences
Oksana Drapkina — Director, National Medical Research Center for Preventive Medicine of the Ministry of Health of the Russian Federation
Doctor of medical Sciences, Professor, corresponding member of RAS
Oksana M. graduated from the MMA named after I. M. Sechenov in 1992. From 1992 to 1997 she worked in the intensive care unit of the clinic of internal diseases of MMA named after I. M. Sechenov. From 1997 to 2015 she worked at the Department of internal medicine propaedeutics First Moscow State Medical University named after I. M. Sechenov, where she was promoted from Department assistant to Professor. In 2013, she was Awarded the Russian government prize in the field of education. In 2017 she was appointed to the position of Director of "NMRC PM" of the Ministry of health of Russia.
Professor Drapkina combines ongoing clinical work with research activities.
Awards: diploma of the Ministry of health of Russia, Laureate of the Russian Government prize in education, badge " excellence in health care».
There were defended 16 PhD theses and 1 dissertation for the degree of doctor of medical Sciences under the scientific guidance of O. M. Drapkina, more than 600 scientific article were published in domestic and foreign journals, 7 monographs, 10 textbooks
Olga Kobyakova — Director, Federal Research Institute for Health Organization and Informatics of Ministry of Health of the Russian Federation
Aleksandr Petrov — Head of the Subcommittee on Circulation of Medicines, Development of the Pharmaceutical and Medical Industry, Committee of the State Duma of the Federal Assembly of the Russian Federation on Health Protection (online)
Farhad Riahi-Nejad — Global Head New Comm Partnership Models and Healthcare Systems Engagement, Novartis (online)
Evgeny Shlyakhto — Director General, Almazov National Medical Research Centre; President, All-Russian Non-Governmental Organization "Russian Society of Cardiology"
Professor Evgeny Shlyakhto, Director General of the Almazov National Medical Research Centre, Academician of the Russian Academy of Science, President of the Russian Society of Cardiology, Fellow of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology.
Professor Shlyakhto was born on June 29, 1954 in Pogar, the Bryansk region. He graduated from the Pavlov Medical University in Saint Petersburg in 1977 and became Doctor of Science in Medicine in 1992, Professor in 1994, Honored Russian Scientist in 2004, and Academician of the Russian Academy of Sciences in 2014.
Evgeny Shlyakhto has been the Director General of the Almazov National Medical Research Centre since 2001 and the President of the Russian Society of Cardiology since 2011. In 2010, he became a member of the WHO Expert Working Group.
The Centre led by Prof. Shlyakhto carries out intensive research in the fields of translational medicine, molecular diagnostics, development of diagnostic tools for personalized treatment, cellular and tissue engineering for therapeutic purposes, creation of biocompatible materials and tissue-engineered constructs designed to create breakthrough medical technologies of fundamental importance for providing high-tech care to patients with cardiovascular, endocrine and blood diseases.
The results of research work by Prof. Shlyakhto have been summarized in more than 800 publications, 16 inventions, 2 scientific discoveries, and a number of monographs. Prof. Shlyakhto was a supervisor in 57 PhD and 20 DSc students..
Professor Shlyakhto is a member of the Presidium of the Russian Academy of Science, the Presidential Council for Science and Education, the Regional Health Council under the Federation Council of the Russian Federal Assembly, the Expert Health Council of the Federation Council Committee on Social Policy of the Russian Federal Assembly, Vice President of the National Medical Chamber.
Evgeny Shlyakhto is the Editor-in-Chief of the following medical journals: Russian Journal of Cardiology, Translational Medicine, and Journal of Arrhythmology. He also is a member of the international editorial board of the European Heart Journal.
Professor Shlyakhto plays an active role in such international committees as the ESC Congress Programme Committee (since 2012) and of the ESC Committee for Practice Guidelines (since 2015).
Evgeny Shlyakhto received the Russian Federation Government Prize in science and technology in 2009 and won the Pavlov Award, the prize for scientific and technological achievement in Physiology and Medicine from the Saint Petersburg Government and St. Petersburg Scientific Center of the Russian Academy of Sciences, in 2011. He received an Order of Honour in 2012 and 4th class Order of Merit for the Motherland in 2017.
Front row participants:
Dmitry Markov — Deputy Prime Minister of the Tula Region; Minister of Health of the Tula Region
Ricardo Martin — Managing Director, Medical Devices, Johnson & Johnson Russia & CIS
Andrey Sarana — First Deputy Chairman of the Health Committee of St. Petersburg (online)